TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
ARVN

Arvinas Inc

Healthcare · Biotechnology

8.30$ -0.2% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Arvinas Inc (ARVN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 250 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ARVN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
35 -43 25 77 102 59 189 22 42 9.5 16 250 317
1.7 1.7 1.7 1.7 1.6 1.2 1.1 9.0
33 -45 24 75 102 59 189 22 42 8.3 15 241 305
86 95 84 94 87 83 91 69 65 61 60 53 238
23 27 24 31 76 34 27 25 22 22 19 24 87
107 121 107 123 163 117 117 94 86 80 77 77 320
-74 -165 -83 -49 -60 -58 71 -72 -44 -72 -63 164 -14
7.1
-64 -153 -69 -35 -49 -46 83 -62 -35 -67 -58 170 10
0.1 1.6 0.1 0.2 0.6 -0.4 0.2 -0.3 0.3 0.2 0.1 0.2 0.8
-64 -155 -69 -35 -49 -45 83 -61 -35 -67 -58 169 9.3
-62 -152 -68 -33 -48 -44 84 -60 -34 -66 -56 159 2.9

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?